Chemed Co. (CHE) Holdings Lowered by Rockefeller Capital Management L.P.
Rockefeller Capital Management L.P. trimmed its position in Chemed Co. (NYSE:CHE) by 1.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 88,576 shares of the company’s stock after selling 1,113 shares during the period. Rockefeller Capital Management L.P.’s holdings in Chemed were worth $28,351,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in the business. Bbva Compass Bancshares Inc. boosted its holdings in shares of Chemed by 1.6% in the first quarter. Bbva Compass Bancshares Inc. now owns 2,518 shares of the company’s stock worth $806,000 after buying an additional 39 shares during the period. Hollencrest Capital Management boosted its holdings in shares of Chemed by 5.9% in the first quarter. Hollencrest Capital Management now owns 768 shares of the company’s stock worth $246,000 after buying an additional 43 shares during the period. Quadrant Capital Group LLC boosted its holdings in shares of Chemed by 184.8% in the first quarter. Quadrant Capital Group LLC now owns 94 shares of the company’s stock worth $26,000 after buying an additional 61 shares during the period. Arizona State Retirement System boosted its holdings in shares of Chemed by 0.6% in the fourth quarter. Arizona State Retirement System now owns 11,492 shares of the company’s stock worth $3,255,000 after buying an additional 68 shares during the period. Finally, Bremer Trust National Association acquired a new position in shares of Chemed in the fourth quarter worth about $25,000. Institutional investors own 87.92% of the company’s stock.
Several research analysts have commented on the stock. Zacks Investment Research cut shares of Chemed from a “hold” rating to a “sell” rating in a report on Thursday, May 9th. ValuEngine cut shares of Chemed from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Oppenheimer raised their target price on shares of Chemed from $340.00 to $370.00 and gave the stock an “outperform” rating in a report on Tuesday, April 30th. Finally, Royal Bank of Canada raised their target price on shares of Chemed from $313.00 to $318.00 and gave the stock a “sector perform” rating in a report on Monday, February 25th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $347.00.
Chemed (NYSE:CHE) last posted its quarterly earnings results on Monday, April 29th. The company reported $2.92 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.96 by ($0.04). The company had revenue of $462.03 million during the quarter, compared to analysts’ expectations of $468.28 million. Chemed had a return on equity of 35.19% and a net margin of 11.37%. Chemed’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period last year, the company earned $2.72 earnings per share. On average, analysts predict that Chemed Co. will post 12.65 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 19th. Stockholders of record on Thursday, May 30th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date is Wednesday, May 29th. Chemed’s dividend payout ratio (DPR) is 10.06%.
In related news, VP Michael D. Witzeman sold 735 shares of the firm’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $328.00, for a total transaction of $241,080.00. Following the transaction, the vice president now owns 4,000 shares of the company’s stock, valued at $1,312,000. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Kevin J. Mcnamara sold 1,400 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $324.52, for a total transaction of $454,328.00. The disclosure for this sale can be found here. Insiders sold 8,781 shares of company stock valued at $2,896,560 over the last three months. 3.96% of the stock is owned by insiders.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Recommended Story: Lock-Up Period Expiration
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.